| |
Non-ischemic CHF N=242 |
Post-ischemic CHFN=147 |
P |
| Age, year |
54 ± 14 |
61 ± 10 |
<0.01 |
| Male, n% |
193 (80%) |
133 (90%) |
<0.01 |
| BMI, kg/m2 |
24 ± 12 |
23 ± 12 |
Ns |
| Hypertension, n% |
99 (41%) |
76 (52%) |
<0.05 |
| Smoking, n% |
136 (56%) |
109 (74%) |
<0.05 |
| Dyslipidemia, n% |
119 (49%) |
107 (72%) |
<0.01 |
| Diabetes mellitus, n% |
44 (18%) |
46 (31%) |
<0.01 |
| CAD extension |
|
|
|
| 1-Vessel, n% |
/ |
40 (27%) |
|
| 2-Vessel, n% |
/ |
46 (31%) |
|
| 3-Vessel, n% |
/ |
61 (42%) |
|
| LVEF, % |
35 ± 6 |
36 ± 8 |
Ns |
| LVV, ml |
187 ± 89 |
203 ± 92 |
Ns |
| Medical treatment |
|
|
|
| Beta-blocker, n% |
213 (87%) |
129 (87%) |
Ns |
| ACE-inhibitor, n% |
191 (82%) |
125 (85%) |
Ns |
| Nitrates, n% |
73 (30%) |
98 (66%) |
<0.01 |
| Ca-antagonist, n% |
29 (12%) |
45 (31%) |
<0.01 |
| Diuretic, n% |
48 (20%) |
31 (21%) |
Ns |
| Statin, n% |
75 (31%) |
123 (84%) |
<0.01 |
| Total cholesterol, mg/dl |
198 ± 57 |
184 ± 56 |
<0.05 |
| HDL cholesterol, mg/dl |
48 ± 22 |
46 ± 23 |
Ns |
| Triglycerides, mg/dl |
144 ± 60 |
156 ± 52 |
Ns |
| Creatinine, mg/dl |
1.2 ± 0.4 |
1.9 ± 0.5 |
Ns |
| WBC, n/ul |
7654 ± 1089 |
8543 ± 1875 |
Ns |
| Hemoglobin, g/l |
13.4 ± 2.3 |
12.2 ± 2.9 |
Ns |
| BNP, pg/ml |
330 ± 237 |
411 ± 187 |
Ns |
| sRAGE, ng/ml |
674 (460-1076) |
598 (432-949) |
Ns |
|
